{
    "clinical_study": {
        "@rank": "92577", 
        "arm_group": [
            {
                "arm_group_label": "Digoxin with/without TA-8995", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Midazolam with/without TA-8995", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "A study in healthy males to look at how multiple doses of TA-8995 affect blood levels and\n      rate of removal of other drugs, using single doses of digoxin and midazolam as examples, to\n      see if there are any potential drug interactions that might affect patients in future\n      studies.  The study will examine whether co-administration of TA-8995 affects the\n      pharmacokinetics of digoxin and midazolam measured by area under the curve (AUC)."
        }, 
        "brief_title": "A Preliminary Drug Drug Interaction Study With TA-8995", 
        "condition": "Pharmacokinetic Interactions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n          -  Healthy male subjects\n\n        Exclusion Criteria\n\n          -  Receiving any other drug therapy\n\n          -  Clinically significant medical history\n\n          -  Abnormal laboratory results or ECGs"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02124954", 
            "org_study_id": "TA-8995-05"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Digoxin with/without TA-8995", 
                    "Midazolam with/without TA-8995"
                ], 
                "intervention_name": "TA-8995", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Midazolam with/without TA-8995", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Digoxin with/without TA-8995", 
                "intervention_name": "Digoxin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Digoxin", 
                "Midazolam"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leeds", 
                    "country": "United Kingdom", 
                    "zip": "LS2 9LH"
                }, 
                "name": "Covance"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "official_title": "A Phase I, Open Label Study to Assess the Effects of TA-8995 on the Pharmacokinetics of Midazolam and Digoxin in Healthy Male Subjects", 
        "overall_contact": {
            "email": "info@xention.com", 
            "last_name": "Patrick Round", 
            "phone": "+44 (0) 1223 493900"
        }, 
        "overall_official": {
            "affiliation": "Covance", 
            "last_name": "Ashley Brooks", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Plasma concentrations of TA-8995, midazolam and digoxin", 
            "safety_issue": "No", 
            "time_frame": "Over 16 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02124954"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Xention Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Xention Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}